Kumarasamy Jayakanthan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kumarasamy Jayakanthan has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
B. Mario Pinto
§Molecular Biology and Biochemistry, Simon Fraser University, 8888 University Dr., Burnaby V5A 1S6, Canada
7 shared publications- B. Mario Pinto
Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada V5A 1S6
6 shared publications David R. Rose
Department of Biology, University of Waterloo, Waterloo, Ontario, N2L 3G1 (Canada)
6 shared publicationsSankar Mohan
Department of Chemistry, Simon Fraser University, Burnaby, BC V5A 1S6, Canada
6 shared publicationsBlair D. Johnston
Department of Chemistry, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6 Canada
3 shared publicationsLyann Sim
3 shared publications
Latest Publications
- Open Access
- 1 November 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (47) , 40021-40030
Metabolic Inhibition of Sialyl-Lewis X Biosynthesis by 5-Thiofucose Remodels the Cell Surface and Impairs Selectin-Mediated Cell Adhesion
- 1 November 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (47) , 40021-40030
Open AccessMetabolic Inhibition of Sialyl-Lewis X Biosynthesis by 5-Thiofucose Remodels the Cell Surface and Impairs Selectin-Mediated Cell Adhesion
- 11 July 2012
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 40 (3) , 273-276
Antiviral activities of sulfonium-ion glucosidase inhibitors and 5-thiomannosylamine disaccharide derivatives against dengue virus
- 11 July 2012
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 40 (3) , 273-276
Antiviral activities of sulfonium-ion glucosidase inhibitors and 5-thiomannosylamine disaccharide derivatives against dengue virus
- 19 January 2012
- Published by Wiley in ChemBioChem
- Vol. 13 (3) , 392-401
5-Thiomannosides Block the Biosynthesis of Dolichol-Linked Oligosaccharides and Mimic Class I Congenital Disorders of Glycosylation
In a cell‐based assay for novel inhibitors, we have discovered that two glycosides of 5‐thiomannose, each containing an interglycosidic nitrogen atom, prevented the correct zymogen processing of the prohormone proopiomelanocortinin (POMC) and the transcription factor sterol‐regulatory element‐binding protein‐2 (SREBP‐2) in mouse pituitary cells and Chinese hamster ovary (CHO) cells, respectively. In the case of SREBP‐2, these effects were correlated with the altered N‐linked glycosylation of subtilisin/kexin‐like isozyme‐1 (SKI‐1), the protease responsible for SREBP‐2 processing under sterol‐limiting conditions. Further examination of the effects of these compounds in CHO cells showed that they cause extensive protein hypoglycosylation in a manner similar to type I congenital disorders of glycosylation (CDGs) since the remaining N‐glycans in treated cells were complete (normal) structures. The under‐glycosylation of glycoproteins in 5‐thiomannoside‐treated cells is now shown to be caused by the compromised biosynthesis of the dolichol‐linked oligosaccharide (DLO) N‐glycosylation donor, although the nucleotide sugars required for the synthesis of DLOs were neither reduced under these conditions, nor were their effects reversed upon the addition of exogenous mannose. Analysis of DLO intermediates by fluorophore‐assisted carbohydrate electrophoresis demonstrated that 5‐thiomannose‐containing glycosides block DLO biosynthesis most likely at a stage prior to the GlcNAc2Man3 intermediate, on the cytosolic face of the endoplasmic reticulum.
- 19 January 2012
- Published by Wiley in ChemBioChem
- Vol. 13 (3) , 392-401
5-Thiomannosides Block the Biosynthesis of Dolichol-Linked Oligosaccharides and Mimic Class I Congenital Disorders of Glycosylation
In a cell‐based assay for novel inhibitors, we have discovered that two glycosides of 5‐thiomannose, each containing an interglycosidic nitrogen atom, prevented the correct zymogen processing of the prohormone proopiomelanocortinin (POMC) and the transcription factor sterol‐regulatory element‐binding protein‐2 (SREBP‐2) in mouse pituitary cells and Chinese hamster ovary (CHO) cells, respectively. In the case of SREBP‐2, these effects were correlated with the altered N‐linked glycosylation of subtilisin/kexin‐like isozyme‐1 (SKI‐1), the protease responsible for SREBP‐2 processing under sterol‐limiting conditions. Further examination of the effects of these compounds in CHO cells showed that they cause extensive protein hypoglycosylation in a manner similar to type I congenital disorders of glycosylation (CDGs) since the remaining N‐glycans in treated cells were complete (normal) structures. The under‐glycosylation of glycoproteins in 5‐thiomannoside‐treated cells is now shown to be caused by the compromised biosynthesis of the dolichol‐linked oligosaccharide (DLO) N‐glycosylation donor, although the nucleotide sugars required for the synthesis of DLOs were neither reduced under these conditions, nor were their effects reversed upon the addition of exogenous mannose. Analysis of DLO intermediates by fluorophore‐assisted carbohydrate electrophoresis demonstrated that 5‐thiomannose‐containing glycosides block DLO biosynthesis most likely at a stage prior to the GlcNAc2Man3 intermediate, on the cytosolic face of the endoplasmic reticulum.
- 30 November 2011
- Published by Wiley in Chemistry – A European Journal
- Vol. 17 (52) , 14817-14825
Probing the Intestinal α‐Glucosidase Enzyme Specificities of Starch‐Digesting Maltase‐Glucoamylase and Sucrase‐Isomaltase: Synthesis and Inhibitory Properties of 3′‐ and 5′‐Maltose‐Extended De‐O‐sulfonated Ponkoranol
The synthesis and glucosidase inhibitory activities of two C‐3′‐ and C‐5′‐β‐maltose‐extended analogues of the naturally occurring sulfonium‐ion inhibitor, de‐O‐sulfonated ponkoranol, are described. The compounds are designed to test the specificity towards four intestinal glycoside hydrolase family 31 (GH31) enzyme activities, responsible for the hydrolysis of terminal starch products and sugars into glucose, in humans. The target sulfonium‐ion compounds were synthesized by means of nucleophilic attack of benzyl protected 1,4‐anhydro‐4‐thio‐D‐arabinitol at the C‐6 position of 6‐O‐trifluoromethanesulfonyl trisaccharides as alkylating agents. The alkylating agents were synthesized from D‐glucose by glycosylation at C‐4 or C‐2 with maltosyl trichloroacetimidate. Deprotection of the coupled products by using a two‐step sequence, followed by reduction afforded the final compounds. Evaluation of the target compounds for inhibition of the four glucosidase activities indicated that selective inhibition of one enzyme over the others is possible.
- 30 November 2011
- Published by Wiley in Chemistry – A European Journal
- Vol. 17 (52) , 14817-14825
Probing the Intestinal α‐Glucosidase Enzyme Specificities of Starch‐Digesting Maltase‐Glucoamylase and Sucrase‐Isomaltase: Synthesis and Inhibitory Properties of 3′‐ and 5′‐Maltose‐Extended De‐O‐sulfonated Ponkoranol
The synthesis and glucosidase inhibitory activities of two C‐3′‐ and C‐5′‐β‐maltose‐extended analogues of the naturally occurring sulfonium‐ion inhibitor, de‐O‐sulfonated ponkoranol, are described. The compounds are designed to test the specificity towards four intestinal glycoside hydrolase family 31 (GH31) enzyme activities, responsible for the hydrolysis of terminal starch products and sugars into glucose, in humans. The target sulfonium‐ion compounds were synthesized by means of nucleophilic attack of benzyl protected 1,4‐anhydro‐4‐thio‐D‐arabinitol at the C‐6 position of 6‐O‐trifluoromethanesulfonyl trisaccharides as alkylating agents. The alkylating agents were synthesized from D‐glucose by glycosylation at C‐4 or C‐2 with maltosyl trichloroacetimidate. Deprotection of the coupled products by using a two‐step sequence, followed by reduction afforded the final compounds. Evaluation of the target compounds for inhibition of the four glucosidase activities indicated that selective inhibition of one enzyme over the others is possible.
- 1 July 2011
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (13) , 3929-3934
Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase
- 1 July 2011
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (13) , 3929-3934
Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase
- 21 May 2010
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 82 (12) , 5323-5330
Capillary Zone Electrophoresis Method for the Separation of Glucosidase Inhibitors in Extracts of Salacia reticulata, a Plant Used in Ayurvedic Treatments of Type-2 Diabetes
A simple and reproducible capillary-zone electrophoresis (CZE) method was developed for the separation and quantitation of sulfonium-ion-containing compounds isolated from plants of the Salacia genus which are traditionally used in Ayurvedic medicine for the treatment of type-2 diabetes. The method sufficiently resolved four different compounds with confirmed glucosidase inhibitory activity, namely, salacinol, ponkoranol, kotalanol and de-O-sulfonated kotalanol. Separation could be achieved in less than 9 min, and calibration curves showed good linearity. Detection limits were determined to be in the low μg/mL range. This method was used to demonstrate that de-O-sulfonated kotalanol isolated from natural sources has identical ionic mobility to a synthetic standard. Furthermore, new extraction conditions were developed by which the zwitterionic compounds (salacinol, ponkoranol, and kotalanol) could be separated from de-O-sulfonated kotalanol in a single solid-phase extraction (SPE) procedure. The extraction gave reproducibly high recoveries and was used to process four commercial Salacia extracts for CZE analysis to reduce the complexity of resulting electropherograms and to facilitate the detection of the four inhibitors in question. De-O-sulfonated kotalanol was detected in two of four Salacia samples while ponkoranol was present in all four. A comparison of all samples tested demonstrated that they had remarkably similar patterns of peaks, suggesting that this CZE method may be useful in the chemical fingerprinting of Salacia-containing products.
- 21 May 2010
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 82 (12) , 5323-5330
Capillary Zone Electrophoresis Method for the Separation of Glucosidase Inhibitors in Extracts of Salacia reticulata, a Plant Used in Ayurvedic Treatments of Type-2 Diabetes
A simple and reproducible capillary-zone electrophoresis (CZE) method was developed for the separation and quantitation of sulfonium-ion-containing compounds isolated from plants of the Salacia genus which are traditionally used in Ayurvedic medicine for the treatment of type-2 diabetes. The method sufficiently resolved four different compounds with confirmed glucosidase inhibitory activity, namely, salacinol, ponkoranol, kotalanol and de-O-sulfonated kotalanol. Separation could be achieved in less than 9 min, and calibration curves showed good linearity. Detection limits were determined to be in the low μg/mL range. This method was used to demonstrate that de-O-sulfonated kotalanol isolated from natural sources has identical ionic mobility to a synthetic standard. Furthermore, new extraction conditions were developed by which the zwitterionic compounds (salacinol, ponkoranol, and kotalanol) could be separated from de-O-sulfonated kotalanol in a single solid-phase extraction (SPE) procedure. The extraction gave reproducibly high recoveries and was used to process four commercial Salacia extracts for CZE analysis to reduce the complexity of resulting electropherograms and to facilitate the detection of the four inhibitors in question. De-O-sulfonated kotalanol was detected in two of four Salacia samples while ponkoranol was present in all four. A comparison of all samples tested demonstrated that they had remarkably similar patterns of peaks, suggesting that this CZE method may be useful in the chemical fingerprinting of Salacia-containing products.
- 1 April 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (8) , 2829-2835
Synthesis of a biologically active isomer of kotalanol, a naturally occurring glucosidase inhibitor
- 1 April 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (8) , 2829-2835
Synthesis of a biologically active isomer of kotalanol, a naturally occurring glucosidase inhibitor
- 9 February 2010
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 12 (5) , 1088-1091
Synthesis and Biological Evaluation of Heteroanalogues of Kotalanol and De-O-Sulfonated Kotalanol
The synthesis of nitrogen and selenium analogues of kotalanol and de-O-sulfonated kotalanol, naturally occurring sulfonium-ion glucosidase inhibitors isolated from Salacia reticulata, and their evaluation as glucosidase inhibitors against the N-terminal catalytic domain of human maltase glucoamylase (ntMGAM) are described.
- 9 February 2010
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 12 (5) , 1088-1091
Synthesis and Biological Evaluation of Heteroanalogues of Kotalanol and De-O-Sulfonated Kotalanol
The synthesis of nitrogen and selenium analogues of kotalanol and de-O-sulfonated kotalanol, naturally occurring sulfonium-ion glucosidase inhibitors isolated from Salacia reticulata, and their evaluation as glucosidase inhibitors against the N-terminal catalytic domain of human maltase glucoamylase (ntMGAM) are described.
- 29 December 2009
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 49 (3) , 443-451
New Glucosidase Inhibitors from an Ayurvedic Herbal Treatment for Type 2 Diabetes: Structures and Inhibition of Human Intestinal Maltase-Glucoamylase with Compounds from Salacia reticulata
An approach to controlling blood glucose levels in individuals with type 2 diabetes is to target α-amylases and intestinal glucosidases using α-glucosidase inhibitors acarbose and miglitol. One of the intestinal glucosidases targeted is the N-terminal catalytic domain of maltase-glucoamylase (ntMGAM), one of the four intestinal glycoside hydrolase 31 enzyme activities responsible for the hydrolysis of terminal starch products into glucose. Here we present the X-ray crystallographic studies of ntMGAM in complex with a new class of α-glucosidase inhibitors derived from natural extracts of Salacia reticulata, a plant used traditionally in Ayuverdic medicine for the treatment of type 2 diabetes. Included in these extracts are the active compounds salacinol, kotalanol, and de-O-sulfonated kotalanol. This study reveals that de-O-sulfonated kotalanol is the most potent ntMGAM inhibitor reported to date (Ki = 0.03 μM), some 2000-fold better than the compounds currently used in the clinic, and highlights the potential of the salacinol class of inhibitors as future drug candidates.
- 29 December 2009
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 49 (3) , 443-451
New Glucosidase Inhibitors from an Ayurvedic Herbal Treatment for Type 2 Diabetes: Structures and Inhibition of Human Intestinal Maltase-Glucoamylase with Compounds from Salacia reticulata
An approach to controlling blood glucose levels in individuals with type 2 diabetes is to target α-amylases and intestinal glucosidases using α-glucosidase inhibitors acarbose and miglitol. One of the intestinal glucosidases targeted is the N-terminal catalytic domain of maltase-glucoamylase (ntMGAM), one of the four intestinal glycoside hydrolase 31 enzyme activities responsible for the hydrolysis of terminal starch products into glucose. Here we present the X-ray crystallographic studies of ntMGAM in complex with a new class of α-glucosidase inhibitors derived from natural extracts of Salacia reticulata, a plant used traditionally in Ayuverdic medicine for the treatment of type 2 diabetes. Included in these extracts are the active compounds salacinol, kotalanol, and de-O-sulfonated kotalanol. This study reveals that de-O-sulfonated kotalanol is the most potent ntMGAM inhibitor reported to date (Ki = 0.03 μM), some 2000-fold better than the compounds currently used in the clinic, and highlights the potential of the salacinol class of inhibitors as future drug candidates.
- 30 March 2009
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (15) , 5621-5626
Structure Proof and Synthesis of Kotalanol and De-O-sulfonated Kotalanol, Glycosidase Inhibitors Isolated from an Herbal Remedy for the Treatment of Type-2 Diabetes
Kotalanol and de-O-sulfonated-kotalanol are the most active principles in the aqueous extracts of Salacia reticulata which are traditionally used in India, Sri Lanka, and Thailand for the treatment of diabetes. We report here the exact stereochemical structures of these two compounds by synthesis and comparison of their physical data to those of the corresponding natural compounds. The candidate structures were based on our recent report on the synthesis of analogues and also the structure−activity relationship studies of lower homologues. The initial synthetic strategy relied on the selective nucleophilic attack of p-methoxybenzyl (PMB)-protected 4-thio-d-arabinitol at the least hindered carbon atom of two different, selectively protected 1,3-cyclic sulfates to afford the sulfonium sulfates. The protecting groups consisted of a methylene acetal, in the form of a seven-membered ring, and benzyl ethers. Deprotection of the adducts yielded the sulfonium ions but also resulted in de-O-sulfonation. Comparison of the physical data of the two adducts to those reported for de-O-sulfonated natural kotalanol yielded the elusive structure of kotalanol by inference. The side chain of this compound was determined to be another naturally occurring heptitol, d-perseitol (d-glycero-d-galacto-heptitol) with a sulfonyloxy group at the C-5 position. The synthesis of kotalanol itself was then achieved by coupling PMB-protected 4-thio-d-arabinitol with a cyclic sulfate that was synthesized from the naturally occurring d-perseitol. The work establishes unambiguously the structures of two natural products, namely, kotalanol and de-O-sulfonated kotalanol.
- 30 March 2009
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (15) , 5621-5626
Structure Proof and Synthesis of Kotalanol and De-O-sulfonated Kotalanol, Glycosidase Inhibitors Isolated from an Herbal Remedy for the Treatment of Type-2 Diabetes
Kotalanol and de-O-sulfonated-kotalanol are the most active principles in the aqueous extracts of Salacia reticulata which are traditionally used in India, Sri Lanka, and Thailand for the treatment of diabetes. We report here the exact stereochemical structures of these two compounds by synthesis and comparison of their physical data to those of the corresponding natural compounds. The candidate structures were based on our recent report on the synthesis of analogues and also the structure−activity relationship studies of lower homologues. The initial synthetic strategy relied on the selective nucleophilic attack of p-methoxybenzyl (PMB)-protected 4-thio-d-arabinitol at the least hindered carbon atom of two different, selectively protected 1,3-cyclic sulfates to afford the sulfonium sulfates. The protecting groups consisted of a methylene acetal, in the form of a seven-membered ring, and benzyl ethers. Deprotection of the adducts yielded the sulfonium ions but also resulted in de-O-sulfonation. Comparison of the physical data of the two adducts to those reported for de-O-sulfonated natural kotalanol yielded the elusive structure of kotalanol by inference. The side chain of this compound was determined to be another naturally occurring heptitol, d-perseitol (d-glycero-d-galacto-heptitol) with a sulfonyloxy group at the C-5 position. The synthesis of kotalanol itself was then achieved by coupling PMB-protected 4-thio-d-arabinitol with a cyclic sulfate that was synthesized from the naturally occurring d-perseitol. The work establishes unambiguously the structures of two natural products, namely, kotalanol and de-O-sulfonated kotalanol.